Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients
- PMID: 28280727
- PMCID: PMC5322420
- DOI: 10.1155/2017/1972429
Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients
Abstract
Background and Objectives. β-Thalassemia and sickle cell disease are genetic disorders characterized by reduced and abnormal β-globin chain production, respectively. The elevation of fetal hemoglobin (HbF) can ameliorate the severity of these disorders. In sickle cell disease patients, the HbF level elevation is associated with three quantitative trait loci (QTLs), BCL11A, HBG2 promoter, and HBS1L-MYB intergenic region. This study elucidates the existence of the variants in these three QTLs to determine their association with HbF levels of transfusion-dependent Saudi β-thalassemia patients. Materials and Methods. A total of 174 transfusion-dependent β-thalassemia patients and 164 healthy controls from Eastern Province of Saudi Arabia were genotyped for fourteen single nucleotide polymorphisms (SNPs) from the three QTL regions using TaqMan assay on real-time PCR. Results. Genotype analysis revealed that six alleles of HBS1L-MYB QTL (rs9376090C p = 0.0009, rs9399137C p = 0.008, rs4895441G p = 0.004, rs9389269C p = 0.008, rs9402686A p = 0.008, and rs9494142C p = 0.002) were predominantly associated with β-thalassemia. In addition, haplotype analysis revealed that haplotypes of HBS1L-MYB (GCCGCAC p = 0.022) and HBG2 (GTT p = 0.009) were also predominantly associated with β-thalassemia. Furthermore, the HBS1L-MYB region also exhibited association with the high HbF cohort. Conclusion. The stimulation of HbF gene expression may provide alternative therapies for the amelioration of the disease severity of β-thalassemia.
Conflict of interest statement
The authors report no conflict of interests.
Figures

Similar articles
-
The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.Blood Cells Mol Dis. 2010 Aug 15;45(2):124-7. doi: 10.1016/j.bcmd.2010.04.002. Epub 2010 May 15. Blood Cells Mol Dis. 2010. PMID: 20472475
-
The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.J Med Genet. 2008 Nov;45(11):745-51. doi: 10.1136/jmg.2008.060335. Epub 2008 Aug 12. J Med Genet. 2008. PMID: 18697826
-
Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.Blood Cells Mol Dis. 2015 Apr;54(4):315-20. doi: 10.1016/j.bcmd.2015.02.001. Epub 2015 Feb 21. Blood Cells Mol Dis. 2015. PMID: 25842369
-
Discovering the genetics underlying foetal haemoglobin production in adults.Br J Haematol. 2009 May;145(4):455-67. doi: 10.1111/j.1365-2141.2009.07650.x. Epub 2008 Mar 2. Br J Haematol. 2009. PMID: 19344402 Review.
-
The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.Med Princ Pract. 2021;30(3):201-211. doi: 10.1159/000511342. Epub 2020 Sep 4. Med Princ Pract. 2021. PMID: 32892201 Free PMC article. Review.
Cited by
-
Responses of β-thalassemia and compound heterozygote of Sickle/βthalassemia of BCL11A Gene Polymorphism in Pakistani Patients.Pak J Med Sci. 2023 Nov-Dec;39(6):1788-1792. doi: 10.12669/pjms.39.6.7183. Pak J Med Sci. 2023. PMID: 37936787 Free PMC article.
-
Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.Indian J Hematol Blood Transfus. 2020 Oct;36(4):705-710. doi: 10.1007/s12288-020-01270-3. Epub 2020 Mar 3. Indian J Hematol Blood Transfus. 2020. PMID: 33100714 Free PMC article.
-
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.BMC Hematol. 2019 Feb 18;19:4. doi: 10.1186/s12878-019-0135-6. eCollection 2019. BMC Hematol. 2019. PMID: 30820323 Free PMC article.
-
Pregnancy and Childbirth: An Unexpected Cakewalk for a Mother With Beta Thalassemia Major Homozygous for IVS (G-C) Mutation.Cureus. 2021 Mar 13;13(3):e13872. doi: 10.7759/cureus.13872. Cureus. 2021. PMID: 33868836 Free PMC article.
-
Haemoglobin switching modulator SNPs rs5006884 is associated with increased HbA2 in β-thalassaemia carriers.Arch Med Sci. 2019 Jul 18;17(4):1064-1074. doi: 10.5114/aoms.2019.86705. eCollection 2021. Arch Med Sci. 2019. PMID: 34336034 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical